Abstract Background Patients with cirrhosis are a risk factor for coagulopathy and bleeding complications. Thromboelastography (TEG) guided therapy is available to rapidly assess guide blood product transfusion in this population. Purpose This study aims determine if TEG-guided able decrease the administration of products reduce adverse events such as mortality compared standard coagulation tes...